Midwest Athletics and Sports Alliance LLC v. Xerox Corp.

CourtDistrict Court, W.D. New York
DecidedAugust 10, 2020
Docket6:19-cv-06036
StatusUnknown

This text of Midwest Athletics and Sports Alliance LLC v. Xerox Corp. (Midwest Athletics and Sports Alliance LLC v. Xerox Corp.) is published on Counsel Stack Legal Research, covering District Court, W.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Midwest Athletics and Sports Alliance LLC v. Xerox Corp., (W.D.N.Y. 2020).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF NEW YORK

MIDWEST ATHLETICS AND SPORTS ALLIANCE LLC,

Plaintiff, DECISION AND ORDER

v. 6:19-CV-06036 EAW

XEROX CORP.,

Defendant.

INTRODUCTION

Plaintiff Midwest Athletics and Sports Alliance LLC (“Plaintiff”) alleges that Defendant Xerox Corp. (“Defendant”) has infringed 20 patents related to printer technology, including United States Patent Number 7,502,582, United States Patent Number 7,720,425, and United States Patent Number 8,005,415 (collectively the “Pentachrome Patents”). (See Dkt. 40). Defendant asserts numerous affirmative defenses and a counterclaim for a declaratory judgment of unenforceability as to the Pentachrome Patents. (Dkt. 117). Currently pending before the Court are Plaintiff’s motion to dismiss Defendant’s counterclaim and fifth, sixth, and seventh affirmative defenses (Dkt. 120) and Defendant’s motion to amend its Answer to the Amended Complaint to add an affirmative - 1 - defense (Dkt. 122).1 For the reasons set forth below, the Court grants in part and denies in part Plaintiff’s motion to dismiss and to strike and grants Defendant’s motion to amend. BACKGROUND

As noted above, Plaintiff has asserted against Defendant claims of infringement related to 20 patents, including the Pentachrome Patents. (See Dkt. 40). Plaintiff is not the original owner of the patents in suit, having acquired them from Eastman Kodak Co. (“Kodak”) shortly before this action was commenced. (Dkt. 122-1 at 5). The Pentachrome Patents are subject to a terminal disclaimer2 with United States Patent Numbers 7,236,734

and 7,340,208 (collectively the “Terminal Disclaimer Patents”). (Dkt. 117 at 13). Kodak “overcame double patenting rejections [as to the Pentachrome Patents] by terminally

1 A special master has been appointed in this case (Dkt. 106; Dkt. 108), and Plaintiff has filed objections to the special master’s recommendation regarding case narrowing (Dkt. 157), which Defendant has opposed (Dkt. 161). The Court will resolve Plaintiff’s objections by separate decision in due course.

2 “A ‘terminal disclaimer’ refers to a procedure by which patent applicants obviate and thereby cure an obviousness-type double patenting rejection by disclaiming any rights in the second application after the expiration date of the original patent. Because the second patent will now expire at the same time as the first one, the concerns that underlie an obviousness-type double patenting rejection are alleviated and the second patent can issue, giving applicants the benefits of having their improvements protected.” Affymetrix, Inc. v. PE Corp., No. 01 CIV. 0634 (NRB), 2002 WL 31875401, at *2 n.4 (S.D.N.Y. Dec. 24, 2002) (citation omitted); see also Gilead Scis., Inc. v. Natco Pharma Ltd., 753 F.3d 1208, 1213 (Fed. Cir. 2014) (explaining that “35 U.S.C. § 253’s terminal disclaimer provision provide[s] patent owners a remedy against a double patenting charge by permitting the patentee to cut back the term of a later issued patent so as to expire at the same time as the earlier issued patent” (quotation and original alteration omitted)). “[A] terminal disclaimer filed to overcome an obviousness-type double patenting rejection is effective only where the application and conflicting patent are commonly owned.” In re Hubbell, 709 F.3d 1140, 1148 (Fed. Cir. 2013). - 2 - disclaiming them to the Terminal Disclaimer Patents.” Midwest Athletics & Sports All. LLC v. Ricoh USA, Inc., No. CV 19-514, 2019 WL 3387061, at *1 (E.D. Pa. July 25, 2019) (the “Ricoh Action”). “On December 9, 2016, Kodak assigned the Terminal Disclaimer

Patents to Commercial Copy Innovations, Inc. (CCI). On June 29, 2017, Kodak assigned the Pentachrome Patents to [Plaintiff].” Id. On April 18, 2019, Plaintiff and CCI entered into an agreement whereby CCI assigned its interest in the Terminal Disclaimer Patents to Plaintiff. Id. Plaintiff has taken the position, both in this action and in the Ricoh Action, that it

owned the Terminal Disclaimer Patents prior to its agreement with CCI in April 2019, and that its agreement with CCI merely “confirmed” its ownership. Id. at *3; (see also Dkt. 120-1 at 7 (“[O]n April 18, 2019, MASA confirmed its ownership of the Terminal Disclaimer Patents through its agreement with [CCI.]”)). However, as the Ricoh court explained, “[e]ven if Kodak had purported to assign [Plaintiff] the Terminal Disclaimer

Patents when it assigned [Plaintiff] the Pentachrome Patents, which it did not, it could not have done so because Kodak had already assigned the Terminal Disclaimer Patents to CCI.” 2019 WL 3387061, at *3. Accordingly, the agreement between Plaintiff and CCI “did not ‘confirm’ [Plaintiff’s] ownership of the Terminal Disclaimer Patents. It transferred ownership of them to [Plaintiff].” Id.

On September 12, 2019, the parties stipulated to the voluntarily dismissal without prejudice from the instant action of “any and all claims relating to” the Pentachrome

- 3 - Patents. (Dkt. 115 at 1). The parties further stipulated that Plaintiff would file a new action asserting the same claims against Defendant and that Defendant would not oppose a motion by Plaintiff to consolidate the to-be-filed action with the instant action. (Id.).

Plaintiff thereafter commenced a new action in this District asserting its claims related to the Pentachrome Patents. Complaint, Midwest Athletics and Sports Alliance LLC v. Xerox Corp, No. 6:19-cv-06665, Dkt. 1 (W.D.N.Y. Sept. 12, 2019) (the “Pentachrome Complaint”). On September 26, 2019, the Court granted Plaintiff’s unopposed motion to consolidate the newly filed action in the instant matter. Midwest Athletics and Sports

Alliance LLC v. Xerox Corp, No. 6:19-cv-06665, Dkt. 9 (W.D.N.Y. Sept. 26, 2019). Defendant filed its Answer to the Pentachrome Complaint on October 24, 2019. (Dkt. 117). Defendant also asserted a counterclaim for a declaratory judgment of unenforceability as to the Pentachrome Patents. (Id.). On November 14, 2019, Plaintiff filed the pending motion to dismiss Defendant’s counterclaim and strike its fifth, sixth, and

seventh affirmative defenses as to the Pentachrome Complaint. (Dkt. 120). On November 22, 2019, Defendant filed the pending motion to amend its Answer to the Amended Complaint. (Dkt. 122). In particular, Defendant seeks leave to “assert the defense of express or implied license and patent exhaustion.” (Id. at 1). Defendant filed its opposition to Plaintiff’s motion to dismiss and to strike on

December 5, 2019. (Dkt. 126). Plaintiff filed its reply on December 12, 2019. (Dkt. 131).

- 4 - Plaintiff filed its opposition to Defendant’s motion to amend on December 18, 2019. (Dkt. 133). Defendant filed its reply on January 2, 2020. (Dkt. 144). DISCUSSION

I. Plaintiff’s Motion to Dismiss and to Strike A. Request for Dismissal of Defendant’s Counterclaim 1. Legal Standard “A motion to dismiss a counterclaim is evaluated under the same standard as a motion to dismiss a complaint.” Radiancy, Inc. v. Viatek Consumer Prods. Grp., Inc., 138

F. Supp. 3d 303, 313 (S.D.N.Y. 2014) (quotation omitted). “In considering a motion to dismiss for failure to state a claim pursuant to Rule 12(b)(6), a district court may consider the facts alleged in the [counterclaim], documents attached to the [counterclaim] as exhibits, and documents incorporated by reference in the [counterclaim].” DiFolco v. MSNBC Cable L.L.C., 622 F.3d 104, 111 (2d Cir. 2010). A court should consider the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Turkmen v. Ashcroft
589 F.3d 542 (Second Circuit, 2009)
Holmes v. Grubman
568 F.3d 329 (Second Circuit, 2009)
McCarthy v. Dun & Bradstreet Corp.
482 F.3d 184 (Second Circuit, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
DiFolco v. MSNBC Cable L.L.C.
622 F.3d 104 (Second Circuit, 2010)
In Re Fallaux
564 F.3d 1313 (Federal Circuit, 2009)
ACUMED LLC v. Stryker Corp.
551 F.3d 1323 (Federal Circuit, 2008)
In Re Hubbell
709 F.3d 1140 (Federal Circuit, 2013)
Kassner v. 2nd Avenue Delicatessen Inc.
496 F.3d 229 (Second Circuit, 2007)
Gilead Sciences, Inc. v. Natco Pharma Limited
753 F.3d 1208 (Federal Circuit, 2014)
Regeneron Pharmaceuticals, Inc. v. Merus N.V.
864 F.3d 1343 (Federal Circuit, 2017)
Gilead Sciences, Inc. v. Merck & Co., Inc.
888 F.3d 1231 (Federal Circuit, 2018)
GEOMC Co., Ltd. v. Calmare Therapeutics Inc.
918 F.3d 92 (Second Circuit, 2019)
Aptix Corp. v. Quickturn Design Systems, Inc.
269 F.3d 1369 (Federal Circuit, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
Midwest Athletics and Sports Alliance LLC v. Xerox Corp., Counsel Stack Legal Research, https://law.counselstack.com/opinion/midwest-athletics-and-sports-alliance-llc-v-xerox-corp-nywd-2020.